FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and Compounded "semaglutide" is not FDA approved semaglutide.com How different peptide therapies may affect your body Prenuvo blog The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times